Summary
Following the introduction of numerous highly effective drugs in recent decades, haematologists are confronted with a panmyelopathy or “toxic myelopathy” originating from the exhibition of certain therapeutic regimens. Among 16,711 trephines referred to us in the last 5 1/2 years, 57 cases or 0.34 percent were found to have clear evidence of lesions caused by the ingestion of potentially toxic agents. The evaluation of the histopathology shows two groups of alterations which concern the haematopoietic parenchyma as well as the mesenchyme of the bone marrow. Different degrees of cellularity ranging from aplasia to regenerative hyperplasia and a pronounced mesenchymal reaction with proteinaceous oedema, perivascular plasmacytosis and frequent necrobiosis of neutrophilic granulocytes or cellular debris are the most conspicuous features. However, the histopathology of the bone marrow described gives no indication of the specific drug responsible and no specific suggestion of any group of drugs. Generally the histopathology allows the recognition of lesions which are induced by the toxicity of these agents. Therefore a bone marrow biopsy should be included in the diagnostic procedures whenever a toxic lesion is suspected of causing haematological disorders, particularly in all cases of uncertain pancytopenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alter BP, Potter NU, Li FP (1978) Classification and aetiology of the aplastic anaemias. Clin Haemat 7:431–465
Baudach A (1972) Beeinflussung der Hämatopoese durch Arzneimittel. Zeitschr Ärztl Fortbild 66:657–659
Bithell TC, Wintrobe MM (1967) Drug-induced aplastic anaemia. Semin Hemat 4:194–221
Burkhardt R (1970) Farbatlas der klinischen Histopathologie von Knochenmark und Knochen. Springer Berlin Heidelberg New York
Burkhardt R (1975) Die Histomorphologie der Knochenmarkinsuffizienz. Haemat Bluttransf 16:112–134
Burkhardt R, Frisch B, Bard R (1982) Bone biopsy in haematological disorders. J Clin Pathol 25:257–284
Chang HK, Morrison SL (1979) Bone-marrow suppression associated with cimetidine. Ann Intern Med 91:580–591
De Gruchy GC (1975) Drug-induced blood disorders. Blackwell Scientific Publication, Oxford
Druart F, Frocrain C, Metois P, Martin J, Matuchansky C (1979) Association of cimetidine and bone marrow suppression in man. Dig Dis Sci 35:730–731
Ell C, Domschke S, Domschke W (1982) Nutzen-Risiko-Abwägung für die Metimazol-Behandlung. Rationale Empfehlungen zur Indikation und Kontraindikation nach dem gegenwärtigen Wissensstand. Fortschr Med 100:615–618
Fischer R, Fohlmeister I (1984) Pathology of Panmyelophthisis. In: Lennert K (ed) Histopathology of the bone marrow, G. Fischer Verlag, Stuttgart New York (in press)
Glogner P, Heni N (1976) Panzytopenie nach Kombinationsbehandlung mit Allopurinol und Azathioprin. Med Welt 27:1545–1546
Gmür J (1980) Die aplastische Anämie (Panzytopenie). In: Frick P, von Harnack GA, Martini GA, Prader A (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde, Springer, Berlin Heidelberg New York pp 145–213
Hausmann K, Skrandies G, Sachtleben P (1974) Aktuelle Aspekte arzneimittelbedingter Knochenmarksschäden. Münch Med Wochenschr 116:1621–1626
Heimpel H, Heit W (1984) Aplastic anemia: pathogenesis and clinical aspects. In: Lennert K (ed) Histopathology of the bone marrow. G. Fischer Verlag, Stuttgart New York (in press)
Heimpel H, Kern P (1976) Arzneimittelbedingte Panmyelopathien. Blut 33:1–10
Heimpel H, Rehbock Chr, van Eimeren W (1975) Verlauf und Prognose der Panmyelopathie und isolierter aplastischer Anämie. Eine retrospektive Studie an 70 Patienten. Blut 30:235–254
Islam A, Catovsky D, Galton DAG (1980) Histological study of bone marrow regeneration following chemotherapy for acute myeloid leukaemia and chronic granulocytic leukaemia in blast transformation. Br J Haematol 45:535–540
Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture. A new biopsy device. J Lab Clin Med 77:335–342
Kelton JG, Huang AT, Mold N, Logue G, Rosse WF (1979) The use of in-vitro technics to study drug-induced pancytopenia. New Engl J Med 301:621–624
Krech R, Georgii A, Vykoupil KF, Bodenstein H, Poliwoda H (1982) Die Veränderungen des Knochenmarkes unter der Chemotherapie von akuten Leukämien. Verh Dtsch Ges Pathol 66:512
Liu YK, Hymowitz R, Carroll MG (1978) Marrow aplasia induced by colchicine. A case report. Arthritis Rheum 21, 6:731–735
Remmele W (1972) Arzneischäden am Knochenmark. Verh Dtsch Ges Pathol 56:291–310
Ring J (1982) Arzneimittelbedingte Unverträglichkeitsreaktionen. Probleme der Terminologie. Dtsch Ärztebl 79 (49):33–37
Shimamine T, Mori S, Itoyama S, Fuji K, Kamiyama R, Matsuja S (1981) Histopathology of bone marrow biopsy in aplastic anemia. Its relation to prognosis of the patients. Acta Haemat Jpn 44:1306–1312
Siegmeth W (1971) Unerwünschte Auswirkungen von Phenylbutazon auf das hämopoetische Gefäß-, Blutungs- und Gerinnungssystem. Wien Med Wochenschr 121:784–790
Vykoupil KF, Thiele J, Georgii A (1976) Histochemical and immunohistochemical techniques on acrylate embedded bone biopsies. Blut 32:215–218
Wohlenberg H (1972) Aplastische Anämie nach Goldbehandlung. Bericht über eine Spätreaktion mit einer Übersicht über 32 Fülle der Weltliteratur. Med Welt 23:971–974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krech, R., Thiele, J. Histopathology of the bone marrow in toxic myelopathy. Vichows Archiv A Pathol Anat 405, 225–235 (1985). https://doi.org/10.1007/BF00704374
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00704374